TABLE 2.
Univariable Fine‐Gray model results for recurrence with clinical and pathological variables
| Subdistribution Hazard ratio (95% CI) | p‐value | |
|---|---|---|
| Age (per year) | 1.00 (0.98–1.02) | 0.72 |
| Tumor size (per cm) | 1.21 (1.14–1.28) | <0.001 |
| Stage | ||
| T2 | 2.25 (1.10–4.61) | 0.03 |
| T3 | 3.72 (2.23–6.20) | <0.001 |
| Furman grade | ||
| G2 | 1.01 (0.15–6.79) | 0.99 |
| G3 | 1.82 (0.27–12.14) | 0.54 |
| G4 | 4.14 (0.59–28.81) | 0.15 |
| Necrosis | 1.99 (0.57–6.93) | 0.28 |
| Lymph node positive | 10.93 (4.77–25.06) | <0.001 |
| Recurrence score (Per 25 RS) | 2.04 (1.49–2.79) | <0.001 |
| Recurrence score | ||
| Intermediate | 1.64 (0.94–2.86) | 0.08 |
| High | 2.95 (1.70–5.12) | <0.001 |
| SSIGN score | 1.39 (1.26–1.54) | <0.001 |
| Intermediate | 4.11 (1.99–8.49) | <0.001 |
| High | 8.16 (3.92–16.98) | <0.001 |